Shellie Ellis, PhD, MPH
Principal Investigator

Dr. Shellie Ellis studies quality of cancer care to identify ways to support cancer care providers in providing the highest quality of care to their patients. Much of her research focuses on improving care delivered to patients with urological cancers. She is passionate about ensuring that patients in underserved areas receive top quality care.

Mugur Geana, MD, PhD
Co-Investigator

Dr. Geana is Associate Professor of Strategic Communication at the University of Kansas and Director of the Center for Excellence in Health Communication to Underserved Populations. Dr. Geana is a graduate (MD) of the Institute of Medicine and Pharmacy, Bucharest, Romania, and of the University of Missouri (PhD). His research focuses on media effects and on developing persuasive health communication campaigns, with emphasis on web and mobile multimedia.

Christine Mackay, RN, PhDc
Co-Investigator

As a member of the LIR team, Christine hopes to understand the barriers community urology practices face in discussing clinical trial participation with their patients and to provide support and resources to aid in these discussions. Increased awareness of and higher participation in clinical trials are needed as we continue the search for a cure.

Ariel Shifter, BS
Project Manager

Ariel is a current graduate student pursuing her Masters in Health Services Administration. She received her bachelor’s degree in biology and psychology from the University of Missouri – Columbia and went on to work as a Clinical Research Coordinator in Medical Oncology for 2 years before going back to school.

J. Brantley Thrasher, MD
Co-Investigator

Dr. Brantley Thrasher is a Distinguished Professor of Urology. Dr. Thrasher went to the Medical University of South Carolina where he received his Medical Degree. He went on to complete his urology residency at Fitzsimons Army Medical Center and urologic oncology fellowship at Duke University Medical Center. Dr. Thrasher is the President of the American Board of Urology, President of the Society of Urology Chairpersons and Program Directors, immediate Past President of the Society of Urologic Oncology, and a member of the Residency Review Committee for Urology. Dr. Thrasher’s desire to help those going through urological cancer is reflected by the numerous committees and programs he has lead in his career. He is passionate about making clinical trial information more readily available to those going through urological cancer.

Tomas Griebling, MD
Co-Investigator

Dr. Tomas Griebling is a Distinguished Professor in Urology. Dr. Griebling is a graduate from University of Iowa College of Medicine where he also did his urology residency training and fellowship. He has a Master’s degree in Public Health from the University of Kansas and is certified in both general urology and female pelvic medicine and reconstructive surgery by the American Board of Urology. Dr. Griebling’s training and expertise in the field of urology as well as passion to help those going through urology cancer makes him an important asset to urological clinical trial initiatives.

Andrew Zganjar, MD
Co-Investigator

Dr. Andrew Zganjar is a 4th-year urology resident. He received his medical degree from the Medical College of Wisconsin. He plans to pursue a fellowship in urologic oncology after graduation and is interested in fostering collaboration between community urologists and academic urologists.